the hypothesis that abnormal polyGln expansions might huntingtin that contains a stretch of 68 glutamines would be expected to produce HD with a juvenile onset, render huntingtin toxic by facilitating its proteolysis by CPP32 from full-length forms into more toxic N-terminal whereas huntingtin with a stretch of 17 glutamines would not cause disease. fragments.
While a mouse model of HD has contributed signifiTo test whether huntingtin is capable of inducing neurodegeneration in vitro and to determine if the mechacantly to the understanding of the mechanisms of huntingtin-induced neurodegeneration (Mangiarini et al., nisms of death depend on the length of the polyGln stretch, we transfected striatal neurons with wild-type 1996; Davies et al., 1997) , cell-based studies represent a complementary approach, which is also likely to provide or mutant huntingtin (480-68) and analyzed the neurons at various time points following transfection. insight into how huntingtin kills neurons. To characterize the mechanisms of huntingtin-induced neurodegenTo identify cells that were transfected with the huntingtin constructs, neurons were cotransfected with a marker eration, we have developed a cellular model of HD by introducing huntingtin into cultured striatal neurons by gene, ␤-galactosidase. To be certain that each neuron that expressed the marker gene also expressed the transfection and then assaying the effect of huntingtin expression on neuronal survival. We find that huntingtin huntingtin construct, transfections were performed with a high ratio of huntingtin DNA to marker gene DNA (beis capable of inducing neurodegeneration in a cell-specific manner that depends on the presence of the mutween 3:1 and 6:1). Under these circumstances, over 95% of the neurons transfected by the marker gene also tated polyGln stretch. Using this in vitro model of huntingtin-induced neurodegeneration, we find that mutant expressed the huntingtin construct (data not shown). Between 3 and 12 days following transfection, neurons huntingtin acts within the nucleus to induce neurodegeneration by an apoptotic mechanism. Although muwere fixed and immunostained for the expression of huntingtin and ␤-galactosidase. Nuclear morphology tant huntingtin's site of action is in the nucleus, the nuclear aggregates of huntingtin are not sufficient to was visualized with the DNA dye Hoechst 33258. Transfected neurons were analyzed by fluorescence microstrigger neurodegeneration, and surprisingly their formation is not correlated with huntingtin-induced apoptosis.
copy and blindly scored for signs of neurodegeneration. By this analysis, we found that a subpopulation of neuRather, conditions that disrupt the formation of intranuclear inclusions lead to an acceleration of huntingtinrons transfected with mutant huntingtin showed clear signs of neurodegeneration as indicated by neurite loss induced death. These findings suggest that the formation of intranuclear inclusions may not be a critical step or destruction, chromatin condensation, and nuclear pyknosis and fragmentation ( Figure 1A ). We quantified in huntingtin-induced neurodegeneration. We propose that the intranuclear inclusions may instead be part of the number of transfected neurons that exhibited signs of neurodegeneration and found that neurons transfected a protective strategy used by the cell to degrade or inactivate the toxic mutant huntingtin protein.
with 480-68 showed double the rate of death compared to neurons transfected with 480-17 ( Figure 1B ). This 2-fold effect is reproducible and was observed in more Results than 16 independent transfection experiments. The expression plasmids that encode the mutant and Transgenic Expression of Mutant Huntingtin Kills Cultured Neurons in a PolyGln Expansion-and wild-type huntingtin are identical except for the length of their respective polyGln stretches, suggesting that the Cell-Specific Fashion To elucidate the mechanisms of neurodegeneration in difference in the rate of neurodegeneration in transfected neurons is due specifically to the difference in the length HD and to identify factors that might prevent the degenerative process, a cellular model was developed that of the polyGln stretch. To determine if the difference in the ability of the wild-type and mutant huntingtin to recapitulates features of the neurodegenerative process that occurs in HD. For the cellular model to be useful, induce neurodegeneration is due to differences in the accumulation of wild-type or mutant huntingtin, we two important features of HD need to be recapitulated in vitro: (1) huntingtin should kill cultured neurons speciftested whether the amounts of wild-type or mutant huntingtin are similar within transfected neurons. Huntingtin ically when the polyGln stretch is expanded, and (2) the mutated huntingtin should specifically kill the subsets immunofluorescence within single transfected neurons was quantified by serial-section confocal laser microsof neurons that are vulnerable in vivo. We began by testing the effects of transfecting striatal neurons with copy. We found that wild-type and mutant huntingtin are present at similar levels in transfected neurons (data a fragment of huntingtin that corresponds to the first 480 amino acids of the mouse protein that includes the not shown), suggesting that the increase in neurodegeneration caused by mutant huntingtin is not due to the polyGln stretch. This fragment was chosen because it corresponds to the N-terminal fragment obtained when altered expression of the mutant huntingtin relative to the wild-type. Taken together, these results suggest that huntingtin is cleaved by CPP32 (Goldberg et al., 1996) and because truncated fragments of huntingtin have transfected huntingtin containing the expanded polyGln stretch induces striatal neurodegeneration by a mechabeen shown to induce cell death effectively in in vitro models (Cooper et al., 1998; Li and Li, 1998; Martindale nism that specifically involves the action of the expanded polyGln stretch. et al., 1998). The 480-amino acid fragment of huntingtin was expressed in striatal neurons in two different forms, Although huntingtin induces striatal neurodegeneration by a mechanism that depends on the polyGln a wild-type form that contains a CAG expansion encoding 17 glutamines (480-17) and a mutant form that constretch, it remained possible that the mechanism of polyGln-induced toxicity in cultured neurons is different tains a stretch of 68 glutamines (480-68). In humans, Neurons cotransfected by the marker ␤-galactosidase and huntingtin immunostain green and red, respectively. Signs of neurodegeneration and death including a pyknotic, sometimes fragmented nucleus (bottom two rows, right most panels, white arrows) and the absence of neurites can be found in a higher fraction of neurons that express mutant huntingtin compared with neurons that express wild-type huntingtin (compare bottom two rows to top row). Scale bar ϭ 20 m (bottom row, right panel). (B) Neurons transfected by mutant huntingtin show twice the rate of death compared with neurons transfected by wild-type huntingtin. Nine days after transfection there is a statistically significant difference in the death induced by mutant huntingtin (480-68) versus wild-type (480-17). Data are from seven independent experiments (t [19] ϭ 3.2; **P Ͻ 0.01).
than for HD neurons in vivo. To test further whether the huntingtin selectively induced degeneration of the medium spiny, enkephalin-positive subpopulation of striain vitro mechanism of huntingtin-induced neurodegeneration closely recapitulated the in vivo mechanism, we tal neurons, the subset of striatal neurons that are particularly vulnerable in HD (Reiner et al., 1988; Sapp et al. , assessed whether the death induced by transfected huntingtin occurred specifically in the same neuronal 1995). We found that mutant huntingtin induced significantly more death than wild-type huntingtin within ensubpopulations that are vulnerable in HD. This was accomplished by investigating whether mutant huntingtin kephalin-positive striatal neurons ( Figures 2B and 2C ). By contrast, transfected enkephalin-negative striatal could also kill cultured neurons from the hippocampus in vitro, a brain region that is spared in HD (Vonsattel et neurons were resistant to huntingtin toxicity, suggesting that transfected mutant huntingtin induces neurodegenal., 1985) . Whereas the expression of mutant huntingtin doubled the level of neurodegeneration in striatal neueration in vitro in a highly cell-specific manner that recapitulates the pattern found in HD. rons, in hippocampal neurons we found no increase in neuronal death when the mutant huntingtin was expressed ( Figure 2A ). The fact that striatal but not hippocampal neurons are susceptible to the effects of mutant Mutant Huntingtin Induces Neurodegeneration by an Apoptotic Mechanism huntingtin suggests that mutant huntingtin induces neurodegeneration in a cell type-specific manner, similar
Having developed an in vitro model of HD that exhibits important features of neurodegeneration of HD in vivo, to that seen in HD in vivo. The failure of mutant huntingtin to induce neurodegeneration in cultured hippocampal we next investigated the mechanisms by which mutant huntingtin induces neurodegeneration. By immunocytoneurons is not due to the decreased expression of mutant huntingtin in hippocampal neurons relative to striatchemistry, we found evidence of cytopathological features of apoptosis in degenerating striatal neurons al neurons. Quantification of the level of mutant huntingtin in hippocampal and striatal neurons revealed that transfected by mutant huntingtin. Nuclei within degenerating striatal neurons showed chromatin condensation, in these two types of neurons, the amount of mutant huntingtin expressed is similar (data not shown). We nuclear pyknosis, or nuclear fragmentation ( Figure 1A ) and stained positively by terminal deoxynucleotidyl conclude that there are intrinsic differences between hippocampal and striatal neurons that render striatal transferase-mediated dUTP end labeling (TUNEL) (data not shown). This is consistent with studies performed on neurons vulnerable to mutant huntingtin and hippocampal neurons resistant.
postmortem brains from HD patients that demonstrated features of apoptosis within degenerating neurons (DraTo test further the cell-specificity of huntingtininduced neurodegeneration in vitro, we asked if mutant gunow et al., 1995; Portera-Cailliau et al., 1995).
To establish further the role of the apoptotic machinery in huntingtin-induced cell death, we tested whether we could protect neurons against mutant huntingtin by blocking known components of the cellular apoptotic machinery. We found that coexpression with BclX L completely blocked mutant huntingtin-induced neurodegeneration ( Figure 3A) . We also tested the effects of interfering with another component of the apoptosis pathway, the protease/caspase CPP32. The extracellular addition of the small peptide antagonist of CPP32, Ac-DEVD-CHO, also completely blocked huntingtin-induced neurodegeneration ( Figure 3B ). In this experiment, it is likely that Ac-DEVD-CHO is blocking a late CPP32-dependent step in the process of huntingtin-induced apoptosis rather than an earlier step, such as the cleavage of fulllength mutant huntingtin into a smaller toxic form. This is likely because the Ac-DEVD-CHO inhibition was done using neurons that express not full-length huntingtin but rather an N-terminal fragment that corresponds to the fragment that has been proposed to be generated when full-length huntingtin is cleaved by CPP32. Taken together, the microscopic features of cells expressing mutant huntingtin and the protective effects of Ac-DEVD-CHO and BclX L , suggest that mutant huntingtin induces degeneration of striatal neurons by an apoptotic mechanism.
Trophic Factors Protect Neurons against Mutant Huntingtin
The fact that extracellular application of the small molecule inhibitor Ac-DEVD-CHO protected neurons against mutant huntingtin suggested that this cellular model of HD might be used to identify other neuroprotective factors that might be useful therapeutically in HD. We tested the effects on huntingtin-induced apoptosis of two trophic factors: brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF). Both CNTF and BDNF completely protected striatal neurons against huntingtin-induced apoptosis ( Figure 3C ) and may prove efficacious in the treatment of HD. We conclude that the neurons. Using an N-terminal fragment of huntingtin Both Met-enkephalin-negative (solid white arrows) and Met-enkephcontaining the first 171 amino acids of the huntingtin alin-positive (hollow white arrows) neurons transfected with wildcoding sequence, we found by immunostaining that the type huntingtin (480-17) remain healthy (intact nuclei, right panels of the top two rows). In contrast, Met-enkephalin-positive neurons transfected by mutant huntingtin (480-68) commonly degenerate (hollow white arrow, third row from the top) whereas untransfected Met-enkephalin-positive neurons are generally healthy (hollow white a statistically significant increase in the death rate induced by muarrow, bottom row). Scale bar ϭ 15 m (bottom row, right panel).
tant huntingtin (480-68) compared with wild-type huntingtin (480-17) (C) Met-enkephalin-positive (Met-Enkϩ) but not Met-enkephalinwithin Met-enkephalin-positive neurons (t [13] ϭ 4.47; P ϭ 0.0006) but negative (Met-EnkϪ) neurons are susceptible to mutant huntingtinnot within Met-enkephalin-negative neurons (t [13] ϭ 0.28; NS), and the induced degeneration. Data are from four independent experiments; death induced by the 480-68 construct in Met-enkephalin-positive ANOVA revealed significant differences for form of huntingtin ϫ cell neurons is significantly different from all the other cases (Fisher's type (F [1, 26] ϭ 6.59; P ϭ 0.016). Nine days after transfection there is analysis: ***P Ͻ 0.001). Wild-type or mutant huntingtin was transfected with an expression vector encoding the human BclX L protein or with the corresponding empty vector (Control, pcDNAI), and the percentage of death was determined 9 days after transfection. Data are from three independent experiments; ANOVA revealed significant differences for form of huntingtin ϫ vector (F [1, 20] ϭ 7.48; P ϭ 0.0013). There is a statistically significant increase in the death rate induced by mutant huntingtin compared with wild-type huntingtin when transfected with empty vector (t [10] ϭ 2.76; P ϭ 0.02) but not when transfected with BclX L (t [10] ϭ 0.59; NS), and the death induced by the 480-68 construct with the empty vector is significantly different from all the other cases (Fisher's analysis: **P Ͻ 0.01). (B) The extracellular addition of the CPP32 antagonist, Ac-DEVD-CHO, protects neurons against mutant huntingtin. Striatal neurons transfected with the wild-type or mutant huntingtin were treated with the caspase-3 inhibitor Ac-DEVD-CHO, and the percentage of death was determined 9 days after transfection. Data are from three independent experiments; ANOVA revealed significant differences for form of huntingtin ϫ treatment (F [1, 19] ϭ 4.63; P ϭ 0.044). There is a statistically significant increase in the death rate induced by mutant huntingtin compared with wild-type huntingtin without treatment (t [9] ϭ 2.37; P ϭ 0.042) but not with treatment (t [10] ϭ 0.12; NS), and the death induced by mutant huntingtin (480-68) without treatment is significantly different from all the other cases (Fisher's analysis: **P Ͻ 0.01). (C) Brain-derived neurotrophic factor or ciliary neurotrophic factor protects neurons against huntingtin-induced neurodegeneration. Striatal neurons transfected with the wild-type or mutant huntingtin were treated with different trophic factors and apoptosis was determined 9 days after transfection. Data are from three independent experiments; ANOVA revealed significant differences for form of huntingtin ϫ treatment (F [2, 29] ϭ 16.75; P Ͻ 0.0001). Fisher's analysis revealed a significant increase in the death rate induced by mutant huntingtin compared with wild-type huntingtin without treatment (P Ͻ 0.0001) but not when treated with CNTF (P ϭ 0.44; NS) or BDNF (P ϭ 0.10; NS), and the death induced by mutant huntingtin (480-68) without treatment is significantly different from all the other cases (**P Ͻ 0.01).
mutant (171-68-Flag) but not wild-type interfered with intranuclear inclusion formation by directly modifying the ability of mutant huntingtin to aggrehuntingtin appeared in the nucleus as large ovoid aggregates ( Figure 4A ). Perinuclear inclusions were rarely obgate rather than by preventing the accumulation of mutant huntingtin in the nucleus. To test whether mutant served (less than 1% of the transfected neurons). These nuclear aggregates appear similar to the intranuclear huntingtin-NES is capable of aggregating, we tested the effects of leptomycin B, an inhibitor of nuclear export inclusions described in HD patients and in HD transgenic mice (Davies et al., 1997; DiFiglia et al., 1997; Becher et (Nishi et al., 1994; Kudo et al., 1997) , on the ability of mutant huntingtin-NES to form aggregates. We found al., 1998).
We then tested whether nuclear localization was necthat the extracellular addition of leptomycin B led to the formation of intranuclear inclusions within a fraction of essary for huntingtin-induced neurodegeneration. To block the nuclear localization of huntingtin, we added neurons transfected by mutant huntingtin-NES ( Figure  4C , quantitation not shown). In contrast, intranuclear a small nuclear export signal (NES) onto the 171-17-Flag or 171-68-Flag constructs. If huntingtin acts within inclusions were never seen in neurons transfected with wild-type huntingtin-NES and treated with leptomycin the nucleus to trigger apoptosis, then we would predict that the addition of an NES to huntingtin should block the B ( Figure 4C , quantitation not shown) or in untreated neurons transfected with mutant huntingtin-NES (Figure ability of huntingtin to enter the nucleus and to induce neurodegeneration. If huntingtin acts in the cytoplasm 4A). Thus, the addition of an NES to mutant huntingtin appears to block its ability to form intranuclear incluto induce neuronal degeneration, then the addition of an NES to huntingtin might block the accumulation of sions by specifically preventing its accumulation within the nucleus through export of nuclear huntingtin into the huntingtin within the nucleus but it should increase apoptosis. To test whether the addition of an NES to huncytoplasm. Having developed a way to export mutant huntingtin from the nucleus into the cytoplasm within tingtin succeeded in excluding huntingtin from the nucleus, we analyzed transfected cells to see whether neurons, we tested whether the nuclear export of mutant huntingtin increased or decreased apoptosis. We found nuclear inclusion formation was blocked. Whereas mutant huntingtin led to the formation of intranuclear incluthat when mutant huntingtin is exported from the nucleus, the huntingtin protein completely loses its ability sions within approximately 30% of striatal neurons at 9 days following transfection, the addition of an NES to to induce striatal neurodegeneration ( Figures 4A and  4D ). Taken together, these results suggest that mutant mutant huntingtin completely blocked inclusion formation ( Figures 4A and 4B ). The expression of mutant hunhuntingtin is transported from its site of synthesis in the cytoplasm into the nucleus where it acts by unknown tingtin-NES was comparable to the expression of mutant huntingtin lacking the NES as measured by confocal mechanisms to trigger apoptosis. microscopy at a time point preceding the formation of intranuclear inclusions, suggesting that the failure of Intranuclear Inclusions and Huntingtin-Induced Neurodegeneration mutant huntingtin-NES to form intranuclear inclusions is not due to poor expression (data not shown).
A current hypothesis is that huntingtin accumulation within the nucleus leads to neurodegeneration through However, it remained possible that the addition of the short 10-amino acid nuclear export tag to huntingtin the formation of potentially toxic intranuclear inclusions. (D) The addition of a nuclear export signal inhibits mutant huntingtin-induced apoptosis. Wild-type or mutant huntingtin containing an NES sequence was transfected into striatal neurons and assessed for apoptosis 9 days after transfection. Data are from three independent experiments; ANOVA revealed significant differences for the constructs (F [3, 39] ϭ 55.1; P Ͻ 0.0001). Death induced by the NES-171-68-Flag is statistically different from the death induced by 171-68-Flag construct (t [19] ϭ 9.49; P Ͻ 0.0001) but not from the control constructs 171-17-Flag (t [20] ϭ 0.78; NS) and NES-171-17-Flag (t [20] ϭ 0.72; NS), and the death induced by the 171-68-Flag construct is significantly different from all the other cases (Fisher's analysis: ***P Ͻ 0.0001).
It has also been suggested that the formation of intravitro model of HD resemble closely those found in vivo in HD in mice and humans. nuclear inclusions is a parallel process that is unrelated to the central mechanism that leads to neurodegeneraIf ubiquitinated inclusions must form in order for mutant huntingtin to induce neurodegeneration, then the tion. To investigate the role that huntingtin-containing intranuclear inclusions play in the process of huntingtinappearance of inclusions should be detected before significant apoptosis occurs. To compare the developinduced neurodegeneration, we first tested whether the intranuclear inclusions that form in transfected striatal ment of ubiquitinated intranuclear inclusions to the induction of apoptosis, we fixed neurons transfected by neurons resemble the intranuclear inclusions that form in patients with HD or in transgenic mice. One charactermutant huntingtin at various times following transfection. Immunocytochemical analysis revealed that the istic feature of the huntingtin intranuclear inclusions detected in HD transgenic mice and found in human aufraction of striatal neurons expressing mutant huntingtin that exhibits intranuclear inclusions rises to a peak at 6 topsy specimens is that huntingtin within the inclusion is ubiquitinated. By immunocytochemistry using an antidays and then falls back to basal levels at 9 and 12 days posttransfection ( Figure 5B ). By contrast, at 3 and 6 ubiquitin antibody, the huntingtin-containing inclusions that form in cultured striatal neurons transfected with days posttransfection, mutant huntingtin has not yet induced apoptosis in a significant number of cells. Howmutant huntingtin were also found wholly within the nucleus and were in each case ubiquitinated (Figures 4C ever, at 9 and 12 days posttransfection the difference in the percentage of transfected neurons undergoing and 5A). Taken together, the observations that only mutated versions of huntingtin form intranuclear inclusions apoptosis grows substantially. Thus, in cultured striatal neurons, the formation of intranuclear inclusions preand that these aggregates are markedly ubiquitinated show that the intranuclear inclusions that form in the in cedes temporally the appearance of apoptosis.
We obtained further evidence that the formation of mutant huntingtin-containing intranuclear inclusions is not directly correlated with mutant huntingtin-induced cell death by assessing the formation of intranuclear inclusions in striatal neurons that had been protected against mutant huntingtin by cotransfection with BclX L or by the application of Ac-DEVD-CHO, CNTF, or BDNF. None of the protective agents blocked the formation of intranuclear inclusions. Rather, the fraction of mutant huntingtin-transfected neurons that showed intranuclear inclusions was significantly increased when the neurons also expressed BclX L or were exposed to Ac-DEVD-CHO, CNTF, or BDNF ( Figures 6A and 6B ). This suggests that the formation of intranuclear inclusions of huntingtin does not irrevocably commit the neuron to an apoptotic fate. Although neuronal survival was correlated with an increase in the presence of intranuclear inclusions, this result by itself does not necessarily indicate that intranuclear inclusions are protective. Another possibility is that the formation of intranuclear inclusions is sufficient to initiate the apoptotic process but that BclX L and Ac-DEVD-CHO protect neurons against the effects of the nuclear inclusions by interfering with the downstream execution of apoptosis.
To explore the dependence of neurodegeneration upon the formation of intranuclear inclusions, we characterized the relationship between inclusion formation and apoptosis. It has been shown previously that N-terminal fragments of huntingtin form inclusions more readily than full-length forms (Cooper et al., 1998; Li and Li, 1998; Martindale et al., 1998) . If intranuclear inclusions are required for huntingtin-induced apoptosis in striatal neurons, then the efficacy with which differentsized truncated versions of huntingtin induce apoptosis dramatically both in striatal ( Figures 6C and 6E ) and hippocampal neurons ( Figure 6C ). However, we found that the percentage of striatal neurons undergoing apoWe found that the formation of intranuclear inclusions ptosis remained constant when striatal neurons were is not always associated with huntingtin-induced apotransfected with plasmid constructs that direct the exptosis. When hippocampal neurons and striatal neurons pression of different-sized N-terminal fragments of muwere transfected with 480-68, or mutant forms of a tant huntingtin ( Figures 6D and 6F) . Notably, the number smaller 171-amino acid N-terminal fragment of huntingof cells undergoing apoptosis did not correlate with the tin (171-68), we found that in both striatal and hippocampercentage of neurons that formed intranuclear inclupal neurons intranuclear inclusions developed in a sigsions ( Figures 6C-6F ). nificant percentage of the cells ( Figure 6C ). However, We considered the possibility that the full-length muthe 480-68 and 171-68 fragments of huntingtin induced tant huntingtin might form intranuclear inclusions at a CAG expansion-dependent apoptosis in the striatal neuslower rate than the 480-68 and 171-68 proteins. Thererons but not in the hippocampal neurons ( Figure 6D) .
fore, if we analyzed cells at later times after transfection, This indicates that in certain subsets of neurons, mutant we might observe an increase in the number of nuclear huntingtin effectively forms intranuclear inclusions, but inclusions that are present in full-length mutant huntingthe presence of the inclusions is not sufficient to induce apoptosis.
tin transfected neurons. However, we found that as with the 480-68 protein ( Figure 5B ), after 6 days of transfection with the full-length mutant huntingtin, the percentage of neurons containing intranuclear inclusions is greater than the percentage of neurons containing nuclear inclusions after 9 days of transfection ( Figure 6E ). This indicates that the time course with which the fulllength mutant huntingtin forms intranuclear inclusions is not delayed and raises the possibility that full-length mutant huntingtin may be capable of inducing apoptosis without forming discernible intranuclear inclusions.
To examine further the importance of intranuclear inclusions for mutant huntingtin-induced cell death, we analyzed the effect of a dominant interfering mutant of the ubiquitin-conjugating enzyme hCdc34p(CL→S) on the ability of mutant huntingtin to induce intranuclear inclusions formation and neuronal death. A mutant version of hCdc34 (hCdc34p [CL→S] ) in which Cys-88 and Leu-97 have been changed into Ser-88 and Ser-97, respectively, has been shown to inhibit the degradation of the Xenopus cdk inhibitor Xic1 and the ubiquitination of the mammalian cdk inhibitor p27 (Pagano et al., 1995; Yew and Kirschner, 1997) . Since huntingtin-containing intranuclear inclusions are ubiquitinated, we reasoned that we might be able to interfere with the formation of intranuclear inclusions by blocking the ubiquitination of mutant huntingtin. This idea was tested by coexpressing mutant huntingtin and dominant negative hCdc34p(CL→S) in striatal neurons and then determining if intranuclear inclusion formation was blocked and, if so, if mutant huntingtin still induced neurodegeneration in a CAG (D) N-terminal fragments of mutant huntingtin induce apoptosis in striatal but not hippocampal neurons. The percentage of death nuclear inclusions was determined 6 and 9 days after transfection within striatal and hippocampal neurons was determined 9 days for five independent transfections. The percentage of neurons that after transfection. Data are from three independent experiments; exhibit intranuclear inclusions is higher at 6 compared to 9 days ANOVA revealed significant differences for form of huntingtin ϫ cell after transfection. No intranuclear inclusions were detected when type (F [3, 55] ϭ 4.96; P ϭ 0.0041). There is a statistically significant cells were transfected with full-length wild-type huntingtin (data not increase in the death rate induced by the 480-68 and 171-68 forms shown). of huntingtin compared with the 480-17 and 171-17 forms within (F) Full-length mutant huntingtin induces apoptosis in striatal neustriatal neurons (t [23] ϭ 3.46; P ϭ 0.0021 and t [13] ϭ 3.07; P ϭ 0.0089, rons as effectively as more truncated versions of mutant huntingtin. respectively) but not within hippocampal neurons (t [9] ϭ 1.26; NS Wild-type and mutant full-length huntingtin were transfected into and t [10] ϭ 0.04; NS). The rates of death induced by the 480-68 or striatal neurons, and the percentage of neurons undergoing apopto-171-68 forms of huntingtin are significantly different from all the sis was determined 9 days after transfection. Data from four indeother cases (Fisher's analysis: **P Ͻ 0.01).
pendent transfections revealed a significant increase in the death (E) Full-length mutant huntingtin induces the formation of very few rate induced by mutant full-length huntingtin compared to wild-type intranuclear inclusions in striatal neurons. The percentage of intrafull-length huntingtin (t [17] ϭ 2.7; *P Ͻ 0.05).
clude that the formation of huntingtin-containing inclusions is not likely to play a positive role in mediating mutant huntingtin-induced cell death. Instead these observations suggest that the formation of intranuclear inclusions may be part of a cellular strategy for degrading or inactivating toxic forms of huntingtin and, thereby, protecting the cell from the deleterious effects of mutant huntingtin. We have begun to elucidate the mechanisms of hunthe corresponding empty vector (pCS2ϩ), and the percentage of tingtin-induced neurodegeneration and have found that death was determined 6 days after transfection. ANOVA revealed mutant huntingtin translocates to the nucleus to trigger significant differences for forms of huntingtin ϫ vector (F [3, 15] ϭ 13.6; neuronal apoptosis. This finding is in agreement with quirement of nuclear localization of mutant ataxin-1 for pathogenesis and aggregate formation in SCA1 (Klement et al., 1998 [this issue of Cell] ). Within the nucleus, mutant huntingtin forms inclusions, although the peranti-ubiquitin antibody (data not shown). Taken together, these results suggest that the decrease in the centage of neurons that display discernible intranuclear inclusions varies depending on the length of the mutant number of intranuclear inclusions that form in the presence of hCdc34p(CL→S) reflects the fact that under huntingtin fragment that is expressed. Full-length huntingtin forms inclusions very rarely raising the possibility these conditions the ubiquitination of mutant huntingtin is at least partially inhibited and also that the ubiquitinathat the intranuclear inclusions may not play a causal role in mutant-huntingtin induced death. This finding is tion of mutant huntingtin may be a prerequisite for intranuclear inclusion formation.
supported by studies of human HD brains in which the number and the location of inclusions do not correlate Having identified conditions that lead to the inhibition of intranuclear inclusion formation, we next investigated with the pattern of neurodegeneration (C.-A. Gutekunst and S. M. Hersch, personal communication) and by the the effect of hCdc34p(CL→S) on mutant huntingtininduced cell death. In the absence of hCdc34p(CL→S), finding that transgenic mice expressing mutant ataxin-1 in which the self-association domain has been deleted mutant huntingtin induces a significant increase in apoptosis 9 days after transfection while having no detectdevelop a pathological phenotype without forming nuclear aggregates (Klement et al., 1998) . Consistent with able effect at 6 days ( Figures 5B and 7B) . However, when transfected with hCdc34p(CL→S), the 171-68 this possibility is our finding that forms of mutant huntingtin (e.g., full-length mutant huntingtin) that rarely agfragment of huntingtin caused a significant increase in cell death relative to the 171-17 huntingtin fragment as gregate to form inclusions trigger striatal neuron apoptosis as effectively as N-terminal fragments of mutant early as 6 days after transfection ( Figure 7B ). Similar results were obtained when the effect of cotransfection huntingtin (e.g., 171-68), which form inclusions quite frequently. It is possible that differences in the ability of of hCdc34p(CL→S) with the 480-17 or 480-68 fragments of huntingtin was assessed (data not shown). Since the full-length mutant huntingtin and the 480-68 and 171-68 huntingtin fragments to form inclusions reflect a differpresence of hCdc34p(CL→S) in neurons leads to a dramatic decrease in the formation of mutant huntingtin ence in the levels of these proteins that accumulate in striatal neurons with the small fragments accumulating containing intranuclear inclusions, but to an acceleration of CAG expansion dependent cell death, we conto higher levels and therefore forming inclusions more readily. If this proves to be the case it might suggest an excitotoxic model of HD (Emerich et al., 1997) , but whether the effects of CNTF or other agents would prove that lower levels of mutant huntingtin are needed to induce cell death than for intranuclear inclusion foruseful in blocking huntingtin-induced neurodegeneration was unknown. The demonstration here that CNTF mation.
The possibility that intranuclear inclusion formation and BDNF effectively protect neurons against huntingtin-induced death suggests that trophic factor treatmay not be an important step in the mutant huntingtininduced death process is corroborated by our finding ments might be a successful strategy for treating HD. Moreover, understanding the signaling mechanisms by that hCdc34p(CL→S), a dominant interfering form of an ubiquitin-conjugating enzyme, dramatically suppresses which CNTF and BDNF suppress huntingtin-induced apoptosis could provide additional ways of inhibiting the formation of intranuclear inclusions while accelerating huntingtin-induced death in a CAG expansion dethe deleterious effect of the mutant huntingtin protein.
Finally, the NES experiments suggest a completely difpendent manner. Although it is difficult from our analysis to identify the direct site of action of hCdc34p(CL→S), ferent strategy for protecting neurons against mutant huntingtin. If specific molecules within the nuclear envewe can conclude that intranuclear inclusion formation can be dissociated from mutant huntingtin-induced cell lope translocate mutant huntingtin from the cytoplasm into the nucleus, then the selective inhibition of mutant death. Taken together, these findings suggest that huntingtin-containing intranuclear inclusions may form as huntingtin import might protect neurons against the subsequent neurodegeneration. the cell attempts to degrade or inactivate the toxic mutant huntingtin protein. As such, the formation of intranuclear inclusions during mutant huntingtin-induced into the nucleus where mutant huntingtin accumulates Glns) huntingtin in pTL1 that were cloned into pcDNAI (Invitrogen). and induces neurodegeneration. The steps that are necThe Flag epitope was added in phase at the C terminus of essary to translocate mutated huntingtin from the cytoor 171-68 constructs, while an NES derived from the heat-stable plasm into the nucleus are not known. Full-length mutant inhibitor (PKI) of cAMP-dependent protein kinase (Wen et al., 1995) huntingtin is sufficiently large that it would have to be was added at the N terminus.
actively transported across the nuclear envelope to enter the nucleus. Nuclear import may be mediated by a Cell Culture and Transfection Primary cultures of striatal and hippocampal neurons were prepared nuclear localization sequence (NLS) within huntingtin from embryonic (E16-18) rats and transfected as previously de- (Bessert et al., 1995) . It is possible that nuclear import scribed (Finkbeiner et al., 1997) . Forskolin (10 M; Sigma) and IBMX occurs more readily if mutant full-length huntingtin is (100 M; Sigma) were added to the cultures every 2 days starting first proteolysed into smaller fragments (Goldberg et 3 days after transfection. Ac-DEVD-CHO (10 M; Sigma), BDNF (50 al., 1996) . However, this does not explain why mutant ng/ml; Amgen), CNTF (50 ng/ml; Regeneron) were added to the huntingtin, but not wild-type huntingtin, accumulates in cultures every 2 days starting the day of transfection. the nucleus since both mutant and wild-type huntingtin contain the same NLS sequence. Furthermore, it reImmunocytochemistry The method of immunocytochemistry has been previously published mains to be shown that proteolysis is required for full- (Finkbeiner et al., 1997) . Antibodies used include monoclonal antilength huntingtin to become toxic and to induce neuro-␤-galactosidase (1:300; Promega), monoclonal anti-huntingtin 4C8 degeneration.
(1:500; Trottier et al., 1995b) , polyclonal anti-ubiquitin (1:100; DAKO),
The finding that the addition of an NES to huntingtin (Gerber et al., 1994) , selectively transactivating genes the DNA dye Hoechst 33258 (2.5 g/ml, 5 min), and transfected neurons were scored as healthy or apoptotic by morphological critethat directly or indirectly regulate apoptosis. shown that CNTF could prevent neurodegeneration in
